Lessons from the Tc-99m shortage implications of substituting Tl-201 for Tc-99m single-photon emission computed tomography

Circulation: Cardiovascular Imaging

Volumn 6, Issue 5, 2013, Pages 683-691

  Small, Gary R ^a   Ruddy, Terrence D ^a,b   Simion, Oana ^a   Alam, Mohammed ^a   Fuller, Lyanne ^a   Chen, Li ^a   Beanlands, Rob S ^a,b   Chow, Benjamin J W ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Health resources; Technetium; Thallium

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PATIENT REFERRAL; PRIORITY JOURNAL; PROPENSITY SCORE; RADIATION DOSE; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

HEALTH RESOURCES; TECHNETIUM; THALLIUM;

AGED; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEALTH CARE COSTS; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; ODDS RATIO; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIATION DOSAGE; RADIOISOTOPES; RADIOPHARMACEUTICALS; REFERRAL AND CONSULTATION; REGISTRIES; RETROSPECTIVE STUDIES; TECHNETIUM; THALLIUM RADIOISOTOPES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84884498279     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.000585     Document Type: Article

References (47)

1. Small GR, Chow BJ, Ruddy TD. Low-dose cardiac imaging: reducing exposure but not accuracy. Expert Rev Cardiovasc Ther. 2012; 10: 89-104.
2. IMV. 2008 Nuclear Medicine Census and Market Summary Report. Des Planes, IL: IMV; 2008.
3. Thomas GS, Maddahi J. The technetium shortage. J Nucl Cardiol. 2010; 17: 993-998.
4. Dilsizian V, Narula J. Seeking remedy for Molly's woe: time for a thallium pill? J AM COLL CARDIOL. Cardiovasc Imaging. 2009; 2: 375-377.
5. Ballinger JR. Short- and long-term responses to molybdenum-99 shortages in nuclear medicine. Br J Radiol. 2010; 83: 899-901.
6. Pagnanelli RA, Basso DA. Myocardial perfusion imaging with 201Tl. J Nucl Med Technol. 2010; 38: 1-3.
7. Kapur A, Latus KA, Davies G, Dhawan RT, Eastick S, Jarritt PH, Roussakis G, Young MC, Anagnostopoulos C, Bomanji J, Costa DC, Pennell DJ, Prvulovich EM, Ell PJ, Underwood SR. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med Mol Imaging. 2002; 29: 1608-1616.
8. Morise AP, Haddad WJ, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med. 1997; 102: 350-356. (Pubitemid 27249101)
9. Morise AP, Jalisi F. Evaluation of pretest and exercise test scores to assess all-cause mortality in unselected patients presenting for exercise testing with symptoms of suspected coronary artery disease. J Am Coll Cardiol. 2003; 42: 842-850. (Pubitemid 37059742)
10. Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, DiFilippo FP, Ficaro EP, Freeman MR, Hendel RC, Jain D, Leonard SM, Nichols KJ, Polk DM, Soman P; American Society of Nuclear Cardiology. Single photon-emission computed tomography. J Nucl Cardiol. 2010; 17: 941-973.
11. Tandon V, Hall D, Yam Y, Al-Shehri H, Chen L, Tandon K, Beanlands RS, Wells GA, Ruddy TD, Chow BJ. Rates of downstream invasive coronary angiography and revascularization: computed tomographic coronary angiography vs. Tc-99m single photon emission computed tomography. Eur Heart J. 2012; 33: 776-782.
12. Tilkemeier PL, Cooke CD, Ficaro EP, Glover DK, Hansen CL, McCallister BD Jr; American Society of Nuclear Cardiology. American Society of Nuclear Cardiology information statement: Standardized reporting matrix for radio-nuclide myocardial perfusion imaging. J Nucl Cardiol. 2006; 13: e157-e171.
13. Hendel RC, Kostuk W, Beanlands RS, Chaudry F, Ascah KJ, Young H, Ruddy TD. Comparison of Tc-99m sestamibi perfusion imaging and echo-cardiography using an arbutamine infusion for the detection of coronary artery disease. Am J Cardiol. 1997; 79: 1518-1521. (Pubitemid 27251074)
14. Ruddy TD, Yasuda T, Gold HK, Leinbach RC, Newell JB, McKusick KA, Boucher CA, Strauss HW. Anterior ST segment depression in acute inferior myocardial infarction as a marker of greater inferior, apical, and posterolateral damage. Am Heart J. 1986; 112: 1210-1216. (Pubitemid 17193252)
15. Ruddy TD, Gill JB, Finkelstein DM, Strauss HW, McKusick KA, Okada RD, Boucher CA. Myocardial uptake and clearance of thallium-201 in normal subjects: comparison of dipyridamole-induced hyperemia with exercise stress. J Am Coll Cardiol. 1987; 10: 547-556. (Pubitemid 17125623)
16. Cheezum MK, Hulten EA, Taylor AJ, Gibbs BT, Hinds SR, Feuerstein IM, Stack AL, Villines TC. Cardiac CT angiography compared with myocardial perfusion stress testing on downstream resource utilization. J Cardiovasc Comput Tomogr. 2011; 5: 101-109.
17. Ontario ministry of health and long-term care. Schedule of Benefits for Physician Services under the health insurance act. http://www.healthgovonca/ english/providers/program/ohip/sob/physserv/physserv-mn.htl 2012. Accessed July 19, 2012.
18. ASNC. ASNC Comparison Chart of Medicare Payments. 2012 Medicare Physician Fee Schedule. http://www.asnc.org/media/PDFs/ASNCMPFSComparisonChart021412.pdf 2012.
19. Centers for Medicare and Medicaid Services 2012. Physician Fee Schedule. http://www.cmsgov/PFSlookup 2012.
20. Thomas SR, Stabin MG, Castronovo FP. Radiation-absorbed dose from 201Tl-thallous chloride. J Nucl Med. 2005; 46: 502-508.
21. Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, Sgouros G, Bengel FM. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med. 2010; 51: 1592-1599.
22. ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Ann ICRP. 2008; 38: 1-197. doi: 10.1016/j.icrp.2008.08.003.
23. Chow BJ, Freeman MR, Bowen JM, Levin L, Hopkins RB, Provost Y, Tarride JE, Dennie C, Cohen EA, Marcuzzi D, Iwanochko R, Moody AR, Paul N, Parker JD, O'Reilly DJ, Xie F, Goeree R. Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med. 2011; 171: 1021-1029.
24. Gerber TC, Carr JJ, Arai AE, Dixon RL, Ferrari VA, Gomes AS, Heller GV, McCollough CH, McNitt-Gray MF, Mettler FA, Mieres JH, Morin RL, Yester MV. Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention. Circulation. 2009; 119: 1056-1065.
25. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007; 298: 317-323. (Pubitemid 47080486)
26. National Academies. Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation, National Research Council of the National Academies. Health Risks From Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: National Academies Press; 2006.
27. Min JK, Koduru S, Dunning AM, Cole JH, Hines JL, Greenwell D, Biga C, Fanning G, LaBounty TM, Gomez M, Horowitz JM, Hadimitzsky M, Hausleiter J, Callister TQ, Rosanski AR, Shaw LJ, Berman DS, Lin FY. Coronary CT angiography versus myocardial perfusion imaging for nearterm quality of life, cost and radiation exposure: a prospective multicenter randomized pilot trial. J Cardiovasc Comput Tomogr. 2012; 6: 274-283.
28. Nallamothu N, Pancholy SB, Lee KR, Heo J, Iskandrian AS. Impact on exercise single-photon emission computed tomographic thallium imaging on patient management and outcome. J Nucl Cardiol. 1995; 2: 334-338.
29. Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, Beanlands RS, Chow BJ, Branscomb E, Chareonthaitawee P, Weigold WG, Voros S, Abbara S, Yasuda T, Jacobs JE, Lesser J, Berman DS, Thomson LE, Raman S, Heller GV, Schussheim A, Brunken R, Williams KA, Farkas S, Delbeke D, Schoepf UJ, Reichek N, Rabinowitz S, Sigman SR, Patterson R, Corn CR, White R, Kazerooni E, Corbett J, Bokhari S, Machac J, Guarneri E, Borges-Neto S, Millstine JW, Caldwell J, Arrighi J, Hoffmann U, Budoff M, Lima J, Johnson JR, Johnson B, Gaber M, Williams JA, Foster C, Hainer J, Di Carli MF; SPARC Investigators. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol. 2012; 59: 462-474.
30. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, Hirai J, Saga T, Tonami N, Hisada K. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am J Cardiol. 1996; 77: 350-354. (Pubitemid 26061164)
31. Einstein AJ. Breaking America's dependence on imported molybdenum. J AM COLL CARDIOL. Cardiovasc Imaging. 2009; 2: 369-371.
32. Pillai MR, Knapp FF Jr. Overcoming the 99mTc shortage: are options being overlooked? J Nucl Med. 2011; 52: 15N-16N, 28N.
33. Renaud J, Mylonas I, Yip K, Turcotte E, Pibarot P, Maguire C, Gulenchyn K, Wisenberg G, Beanlands RS, deKemp R. Low dose 3D PET rubidium ARMI (Alternative Radiopharmaceutical for Myocardial Imaging) multi-centre trial standards and quality assurance. J Nucl Med. 2012; 53: 1805.
34. MITA. Medical Imaging and Medicare: Five Years Later. A Medical Imaging and Technology Alliance Report. Arlington: MITA; 2011: 1-4.
35. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-1516. (Pubitemid 46588415)
36. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, Hayes SW, Cohen I, Germano G, Berman DS. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial re-vascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011; 32: 1012-1024.
37. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE; COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008; 117: 1283-1291. (Pubitemid 351365675)
38. Moroi M, Yamashina A, Tsukamoto K, Nishimura T; J-ACCESS Investigators. Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia. Int J Cardiol. 2012; 158: 246-252.
39. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM, Williams KA. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009; 119: e561-e587.
40. Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Peterson ED, Hendel RC, Stainback RF, Blaivas M, Des Prez RD, Gillam LD, Golash T, Hiratzka LF, Kussmaul WG, Labovitz AJ, Lindenfeld J, Masoudi FA, Mayo PH, Porembka D, Spertus JA, Wann LS, Wiegers SE, Brindis RG, Douglas PS, Patel MR, Wolk MJ, Allen JM. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. Circulation. 2008; 117: 1478-1497.
41. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA, Masoudi FA, Dehmer GJ, Patel MR, Smith PK, Chambers CE, Ferguson TB, Jr., Garcia MJ, Grover FL, Holmes DR, Jr., Klein LW, Limacher MC, Mack MJ, Malenka DJ, Park MH, Ragosta M, III, Ritchie JL, ROSE GA, Rosenberg AB, Russo AM, Shemin RJ, Weintraub WS, Wolk MJ, Bailey SR, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Shaw L, Stainback RF, Allen JM. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Thorac Cardiovasc Surg. 2012; 143: 780-803.
42. Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O'Gara P, Rubin GD. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Comput Tomogr. 2010; 4: 407-433.
43. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, Knuuti J, Schedlbert HR, Travin MI. PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol. 2009; 16: 651.
44. Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS, Ward RP. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 59: 1995-2027.
45. Einstein AJ, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, Moses JW, Balter S. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010; 304: 2137-2144.
46. Einstein AJ. Medical imaging: the radiation issue. Nat Rev Cardiol. 2009; 6: 436-438.
47. Bateman TM, O'Keefe JH Jr, Dong VM, Barnhart C, Ligon RW. Coronary angiographic rates after stress single-photon emission computed tomo-graphic scintigraphy. J Nucl Cardiol. 1995; 2: 217-223.